|
Drugs and Devices Today - Web Exclusives
printer friendly format email page Issue
| Share

FDA approves DNA test to help manage CMV infection in organ transplant patients

Issue Date: July 2012 Vol. 7 No. 7

0 Comments


On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the progress of anti-viral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy. Read more.

No Comments.